Delivery Order SPE2DB20D2104-SPE2DB24FS91G
Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,046.97 firm fixed-price delivery order is for the supply of 4,567,707,523 units of Cetirizine HCL 10 mg tablets, with a performance period through March 27, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,567,878,956 units of Cetirizine HCL 10 mg tablets. The contract has a ceiling value of $5,295.54 and runs through April 14, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,680.23, is for the delivery of 4,567,781,423 units of Cetirizine HCL 10 mg tablets. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,197.91 firm-fixed-price delivery order is for the supply of 4,562,549,817 units of Cetirizine HCL 5 mg tablets. The contract has an ultimate completion date of October 23, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This is a $3,689.15 firm-fixed-price delivery order awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,568,494,137 units of the drug Cetirizine HCL 5 mg Tablet in 100-count bottles. The delivery order has an ultimate completion date of June 10, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which serves as a comprehensive global...
- This federal contract award, valued at $4,702.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,073,284 units of Cetirizine HCL 10 mg tablets, a prescription medication, with a completion date of April 30, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4564138991 - Cetirizine HCL 5 mg Tablets in 100-count bottles. The contract, with a ceiling value of $19,826.41, has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor, and the contract does not have a set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Cetirizine HCL 10 mg tablets (500 count) valued at $1,461.49 under a firm fixed-price contract. The award was made on December 2, 2025, with an ultimate completion date of December 3, 2025. This delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,686.91 firm fixed-price delivery order covers the supply of 4,566,693,120 units of the drug Cetirizine HCL 10 mg tablets. The award has an ultimate completion date of December 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $1,117.74 and an ultimate completion date of April 16, 2025. The award is for the delivery of 4,567,922,388 units of the pharmaceutical product Cetirizine HCL 5 mg tablets in 100-count packaging. This contract is not set aside and is considered an open competition. AmerisourceBergen Drug Corp holds a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS91GDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $1,907.12 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,563,881,452 units of cetirizine HCL 10 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract does not have a set-aside designation and is expected to be completed by March 7, 2024.
Generated 6/5/24, 10:19 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/6/24 |